{"id":"W4388125640","doi":"10.1097/fpc.0000000000000515","title":"Pharmacogenetics of weight gain following switch from efavirenz- to integrase inhibitor-containing regimens","year":2023,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; National Institute on Aging; Center for AIDS Research, University of Washington; Public Health Agency of Canada; National Institutes of Health; National Center for Research Resources; Public Health Agency; ACT Government; U.S. Department of Veterans Affairs","keywords":"Elvitegravir; Efavirenz; CYP2B6; Weight gain; Dolutegravir; Integrase inhibitor; Pharmacogenetics; Raltegravir; Medicine; Integrase; Internal medicine; Pharmacology; Genotype; Oncology; Virology; Viral load; Human immunodeficiency virus (HIV); Biology; Genetics; Antiretroviral therapy; Body weight; CYP1A2; Cytochrome P450","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002138591,0.0002533108,0.0004096059,0.0002577398,0.0001672623,0.00001943762,0.0001218441,0.00009636698,0.00004292539],"category_scores_gemma":[0.00002535946,0.0002489426,0.0001281837,0.000478594,0.00003773438,0.00002382582,0.0001416334,0.0002014992,0.0001145541],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009688365,"about_ca_system_score_gemma":0.0001549832,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009951375,"about_ca_topic_score_gemma":0.000008651052,"domain_scores_codex":[0.9983465,0.00004229229,0.0005458442,0.0004347437,0.000217918,0.0004126911],"domain_scores_gemma":[0.9988235,0.0001273942,0.0001276925,0.0003197142,0.0001060114,0.0004957134],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0007203523,0.0004984006,0.1355622,0.000173957,0.001660399,0.0002715393,0.005252416,0.0008620648,0.7341005,0.0001298928,0.00484881,0.1159194],"study_design_scores_gemma":[0.02286179,0.002084017,0.06543471,0.0009665599,0.005108808,0.00008199147,0.001638791,0.06094208,0.6424304,0.001690259,0.1950073,0.001753333],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940096,0.002619742,0.0005023313,0.001094397,0.0003601425,0.0006831452,0.000177571,0.00007561021,0.000477493],"genre_scores_gemma":[0.9903749,0.003342105,0.004712206,0.0007405226,0.0002336503,0.00005709313,0.0001970786,0.00006467861,0.0002778076],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1901585,"threshold_uncertainty_score":0.9999963,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02946384636796119,"score_gpt":0.3414378834390306,"score_spread":0.3119740370710695,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}